share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Hart Brett J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Hart Brett J

艾伯维公司 | 4:持股变动声明-董事 Hart Brett J
美股SEC公告 ·  05/07 18:36

Moomoo AI 已提取核心信息

Brett J. Hart, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Hart's direct holdings in AbbVie common stock increased to a total of 18,269 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment to align the interests of its executives with those of its shareholders.
Brett J. Hart, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Hart's direct holdings in AbbVie common stock increased to a total of 18,269 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment to align the interests of its executives with those of its shareholders.
与艾伯维公司 [ABBV] 关联的布雷特·哈特于2024年5月3日获得了1,322股普通股。根据交易代码 “A”,交易是在不向收款人支付任何费用的情况下完成的,该交易表示赠款、奖励或其他收购。在这笔交易之后,哈特直接持有的艾伯维普通股增加到总共18,269股。该补助金是公司薪酬结构的一部分,反映了保持高管利益与股东利益一致的持续承诺。
与艾伯维公司 [ABBV] 关联的布雷特·哈特于2024年5月3日获得了1,322股普通股。根据交易代码 “A”,交易是在不向收款人支付任何费用的情况下完成的,该交易表示赠款、奖励或其他收购。在这笔交易之后,哈特直接持有的艾伯维普通股增加到总共18,269股。该补助金是公司薪酬结构的一部分,反映了保持高管利益与股东利益一致的持续承诺。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息